204 related articles for article (PubMed ID: 16319192)
1. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
[TBL] [Abstract][Full Text] [Related]
2. RAGE expression in the human peritoneal membrane.
Kihm LP; Wibisono D; Müller-Krebs S; Pfisterer F; Morath C; Gross ML; Morcos M; Seregin Y; Bierhaus A; Nawroth PP; Zeier M; Schwenger V
Nephrol Dial Transplant; 2008 Oct; 23(10):3302-6. PubMed ID: 18477569
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
[TBL] [Abstract][Full Text] [Related]
4. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.
De Vriese AS; Tilton RG; Mortier S; Lameire NH
Nephrol Dial Transplant; 2006 Sep; 21(9):2549-55. PubMed ID: 16757496
[TBL] [Abstract][Full Text] [Related]
6. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
7. Human RAGE antibody protects against AGE-mediated podocyte dysfunction.
Müller-Krebs S; Kihm LP; Madhusudhan T; Isermann B; Reiser J; Zeier M; Schwenger V
Nephrol Dial Transplant; 2012 Aug; 27(8):3129-36. PubMed ID: 22510380
[TBL] [Abstract][Full Text] [Related]
8. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
9. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate suppresses peritoneal fibrosis in mice.
Kitamura M; Nishino T; Obata Y; Furusu A; Hishikawa Y; Koji T; Kohno S
Chem Biol Interact; 2012 Jan; 195(1):95-104. PubMed ID: 22101032
[TBL] [Abstract][Full Text] [Related]
11. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
13. GDP and AGE receptors: mechanisms of peritoneal damage.
Schwenger V
Contrib Nephrol; 2006; 150():77-83. PubMed ID: 16720995
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal aging during PD: implication of RAGE, the receptor for AGEs.
Boulanger E; Daroux M
Nefrologia; 2008; 28 Suppl 6():5-10. PubMed ID: 18957005
[TBL] [Abstract][Full Text] [Related]
15. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
[TBL] [Abstract][Full Text] [Related]
16. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
17. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
[TBL] [Abstract][Full Text] [Related]
18. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
Higuchi C; Nishimura H; Sanaka T
Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
[TBL] [Abstract][Full Text] [Related]
19. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
20. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
